Supplementary Figure S2 from Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22–00

crossref(2023)

引用 0|浏览8
暂无评分
摘要

Kaplan-Meier estimates for OS, DFS, DRFI and BCFI measures according to CM maintenance.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要